Skin News and Research

RSS

Contraceptive pill can reduce the risk of type 2 diabetes in women with PCOS, study reveals

A study led by the University of Birmingham has revealed for the first time that the contraceptive pill can reduce the risk of type 2 diabetes by over a quarter in women with polycystic ovary syndrome (PCOS).

15 Oct 2021

Salk researchers discover how the brain ignores distracting signals to coordinate movements

As you read this article, touch receptors in your skin are sensing your environment. Your clothes and jewelry, the chair you're sitting on, the computer keyboard or mobile device you're using, even your fingers as they brush one another unintentionally - each touch activates collections of nerve cells.

15 Oct 2021

New trial shows vaginal laser therapy treatments may not work at all

This laser is supposed to rejuvenate vaginal tissue. But scientists say it’s no better than a placebo.

15 Oct 2021

More than half of COVID-19 survivors experience "long COVID", researchers say

More than half of the 236 million people who have been diagnosed with COVID-19 worldwide since December 2019 will experience post-COVID symptoms - more commonly known as "long COVID" - up to six months after recovering, according to Penn State College of Medicine researchers.

13 Oct 2021

Study shows how tissue-derived T cells can damage other organs in stem cell transplant patients

More than 40,000 allogeneic hematopoietic stem cell transplants are carried out worldwide every year, mostly for patients suffering from leukemia or other diseases of the hematopoietic system.

13 Oct 2021

Impact of BRCA1 mRNA expression on survival of patients breast and colorectal cancer

Oncotarget published "Opposing effects of BRCA1 mRNA expression on patient survival in breast and colorectal cancer and variations among African American, Asian, and younger patients" which reported that LMNB2 is a chromatin remodeling protein that also plays a role in eukaryotic cell proliferation by organizing the nuclear membrane during mitosis.

13 Oct 2021

Study uncovers mechanism that may underlie greater sensitivity of certain skin regions

Some parts of the body - our hands and lips, for example - are more sensitive than others, making them essential tools in our ability to discern the most intricate details of the world around us.

11 Oct 2021

Research provides insights on colorectal cancers’ immunotherapy resistance

Immune checkpoint inhibitors, which unleash the immune response against tumor cells, have revolutionized cancer treatment; however, the medications aren't effective in a large number of patients, including those with colorectal cancer.

11 Oct 2021

Experts address questions on psoriasis patients’ true needs and wellbeing

Almirall S.A., a global biopharmaceutical company focused on skin health, has hosted a scientific session during the 30th EADV Congress which addressed the need and importance to focus on patient wellbeing in real-life clinical practice.

8 Oct 2021

Keeping up Covid-levels of hygiene could help combat deadly antimicrobial resistance

Keeping up Covid-levels of hygiene awareness long-term could help tackle the spread of deadly antimicrobial resistance, according to new research from the University of West London (UWL) and Royal Holloway University of London.

8 Oct 2021

Chilblain-like lesions and COVID-19

The ongoing COVID-19 pandemic brought about by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has also been responsible for various cutaneous manifestations. Among them, chilblain-like lesions (CLL) have been found to occur more frequently.

7 Oct 2021

Abnormal T cell responses to COVID-19 do not appear to be the cause of MIS-C in children

Multisystem inflammatory syndrome in children (MIS-C) is a serious condition associated with a recent COVID-19 infection.

7 Oct 2021

Deadly subtype of T-cell lymphoma harbors unique mutations

An especially deadly subtype of T-cell lymphoma is distinguished by unique mutations in a specific protein signaling pathway, according to a study published in the journal Blood.

7 Oct 2021

New technology shows great promise for early diagnosis of Alzheimer’s disease

A technology developed by scientists at Lawrence Berkeley National Laboratory (Berkeley Lab) shows great promise for diagnosing Alzheimer's disease before symptoms arise, potentially changing the course of research and treatment for this condition, which affects millions of people worldwide and is estimated to be the sixth leading cause of death in the United States.

7 Oct 2021

Functionality testing in the pharmaceutical and medical sectors

In this interview, News-Medical talks to ZwickRoell UK about materials testing in the pharmaceutical and medical industry.

7 Oct 2021

Massage can enhance healing and strength of muscles, study finds

Massage has been used to treat sore, injured muscles for more than 3,000 years, and today many athletes swear by massage guns to rehabilitate their bodies. But other than making people feel good, do these "mechanotherapies" actually improve healing after a severe injury? According to a new study from researchers at Harvard's Wyss Institute for Biologically Inspired Engineering and John A. Paulson School of Engineering and Applied Sciences (SEAS), the answer is "yes."

7 Oct 2021

Protecting the ozone layer could prevent cancer cases and other diseases in the U.S

An international agreement to protect the ozone layer is expected to prevent 443 million cases of skin cancer and 63 million cataract cases for people born in the United States through the end of this century, according to new research.

7 Oct 2021

Psychological therapy alleviates adverse biobehavioral effects in young adult testicular cancer survivors

Psychological therapy reduces the adverse biobehavioral effects of testicular cancer in young adult survivors, according to a pilot study led by the University of California, Irvine.

6 Oct 2021

Gene expression changes during acute SARS-CoV-2 infection may decide long-COVID symptoms

A team of US-based scientists has recently revealed the changes in gene expression profiles associated with the long-term consequences of COVID-19.

6 Oct 2021

First of its kind ‘living medicine’ designed to treat antibiotic-resistant bacteria on medical implants

Researchers at the Centre for Genomic Regulation and Pulmobiotics S.L have created the first 'living medicine' to treat antibiotic-resistant bacteria growing on the surfaces of medical implants. The researchers created the treatment by removing a common bacteria's ability to cause disease and repurposing it to attack harmful microbes instead.

6 Oct 2021

Skin News and Research

Contraceptive pill can reduce the risk of type 2 diabetes in women with PCOS, study reveals

Salk researchers discover how the brain ignores distracting signals to coordinate movements

New trial shows vaginal laser therapy treatments may not work at all

More than half of COVID-19 survivors experience "long COVID", researchers say

Study shows how tissue-derived T cells can damage other organs in stem cell transplant patients

Impact of BRCA1 mRNA expression on survival of patients breast and colorectal cancer

Study uncovers mechanism that may underlie greater sensitivity of certain skin regions

Research provides insights on colorectal cancers’ immunotherapy resistance

Experts address questions on psoriasis patients’ true needs and wellbeing

Keeping up Covid-levels of hygiene could help combat deadly antimicrobial resistance

Chilblain-like lesions and COVID-19

Abnormal T cell responses to COVID-19 do not appear to be the cause of MIS-C in children

Deadly subtype of T-cell lymphoma harbors unique mutations

New technology shows great promise for early diagnosis of Alzheimer’s disease

Functionality testing in the pharmaceutical and medical sectors

Massage can enhance healing and strength of muscles, study finds

Protecting the ozone layer could prevent cancer cases and other diseases in the U.S

Psychological therapy alleviates adverse biobehavioral effects in young adult testicular cancer survivors

Gene expression changes during acute SARS-CoV-2 infection may decide long-COVID symptoms

First of its kind ‘living medicine’ designed to treat antibiotic-resistant bacteria on medical implants

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News